文献速递腹部MR

术前钆塞酸增强MRI影像组学预测肝细胞癌切除后晚期复发

Predicting advanced-stage recurrence in resected hepatocellular carcinoma using preoperative gadoxetic acid-enhanced MRI radiomics.
PubMed 文献 · Abdom Radiol (NY) · 2026-10-13

本研究回顾性纳入BCLC 0/A期肝细胞癌切除患者,基于术前钆塞酸增强MRI提取影像组学特征构建LASSO-Cox模型,预测晚期复发时间。验证队列中模型C-index为0.716,优于术前BCLC和香港肝癌分期系统,与术后临床病理模型相当,且风险分层读者间 reproducibility 良好。

要点

  • 术前MRI影像组学可预测HCC切除后晚期复发,C-index 0.716。
  • 模型性能优于BCLC和香港肝癌分期系统,与术后病理模型相当。
  • 基于肝胆期图像及瘤周3mm扩展提取特征,风险分层重复性好。

局限性

  • 回顾性单中心设计,需外部多中心验证。
  • 仅纳入BCLC 0/A期切除患者,结论外推受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To develop and validate a preoperative gadoxetic acid-enhanced MRI-based radiomics model for predicting the time to advanced-stage recurrence in patients undergoing resection for hepatocellular carcinoma (HCC).

MATERIALS AND METHODS: This retrospective single-center study included patients with Barcelona Clinic Liver Cancer (BCLC) stage 0/A HCC who underwent resection between 2009 and 2014. Patients were temporally divided into training (n = 272; 2009-2011) and validation (n = 210; 2012-2014) cohorts. Time to advanced-stage recurrence was defined as the interval from resection to macrovascular invasion and/or extrahepatic metastasis. Two radiologists segmented tumors on hepatobiliary phase images, followed by 3-mm peritumoral expansion and propagation to co-registered dynamic T1- and T2-weighted images. After extraction of Image Biomarker Standardization Initiative-compliant features, a radiomics model was developed using least absolute shrinkage and selection operator (LASSO)-Cox regression. Model performance and inter-reader reproducibility of binary risk stratification were evaluated using the concordance index (C-index) and Cohen's kappa, respectively.

RESULTS: Five-year advanced-stage recurrence occurred in 15% of the training (42/272) and validation (32/210) cohorts. In the validation cohort, the radiomics model yielded a C-index of 0.716 (95% CI, 0.631-0.801). This outperformed the preoperative BCLC (0.597; 95% CI 0.551-0.644) and Hong Kong Liver Cancer (0.594; 95% CI 0.516-0.672) staging systems, and was equivalent to the postoperative clinicopathological model (0.716; 95% CI 0.626-0.807). Radiomic-based risk stratification showed good inter-reader reproducibility (kappa = 0.757).

CONCLUSION: The preoperative radiomics model outperformed staging systems and was comparable to the postoperative clinicopathological model in predicting advanced-stage recurrence, relying entirely on noninvasive data.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Kang JG, Han K, Ryu L, et al. Predicting advanced-stage recurrence in resected hepatocellular carcinoma using preoperative gadoxetic acid-enhanced MRI radiomics. Abdom Radiol (NY). 2026. PMID: 42867538. doi:10.1007/s00261-026-05816-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。